No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use
-
Biomarkers, Tumor
-
Catheter Ablation
-
Cryosurgery
-
Diagnostic Imaging
-
Embolization, Therapeutic
-
Hepatic Artery
-
Humans
-
Liver Transplantation
-
Multiple Endocrine Neoplasia Type 1 / pathology
-
Multiple Endocrine Neoplasia Type 1 / therapy
-
Neoadjuvant Therapy
-
Neoplasm Grading
-
Neoplasm Staging
-
Neuroendocrine Tumors / diagnosis*
-
Neuroendocrine Tumors / epidemiology
-
Neuroendocrine Tumors / therapy*
-
Pancreatectomy
-
Pancreatic Neoplasms / diagnosis*
-
Pancreatic Neoplasms / epidemiology
-
Pancreatic Neoplasms / therapy*
-
Pancreaticoduodenectomy
-
Prognosis
-
Radioisotopes / therapeutic use
-
Receptors, Peptide / metabolism
-
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
-
Somatostatin / analogs & derivatives
-
TOR Serine-Threonine Kinases / antagonists & inhibitors
-
World Health Organization
Substances
-
Angiogenesis Inhibitors
-
Biomarkers, Tumor
-
Radioisotopes
-
Receptors, Peptide
-
Somatostatin
-
Receptors, Vascular Endothelial Growth Factor
-
TOR Serine-Threonine Kinases
-
pentetreotide